Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females
A novel and effective method to quantitatively assess the risk of MASLD-HCC progression in female patients was developed, and this method will aid in the generation of precise diagnostic, preventive, and therapeutic strategies.
Authors
- Guolong Liu (ORCID: https://orcid.org/0000-0002-8336-1703)
- Y F Li (ORCID: https://orcid.org/0009-0007-0060-2166)
- Lin Xu (ORCID: https://orcid.org/0000-0002-0537-922X)
- Yun Zhou (ORCID: https://orcid.org/0000-0003-2909-8796)
- Xiaoning Gan
Institutions
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Michigan State University (US)
- South China University of Technology (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1007/s12672-024-01636-3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China